CAR-T cell researchers optimistic about future of treating blood cancers
Survival outcomes using chimeric antigen receptor-T cell therapy (CAR-T cell therapy) continue to be impressive for patients with some blood cancers.
Sep 15, 2023
0
2
Survival outcomes using chimeric antigen receptor-T cell therapy (CAR-T cell therapy) continue to be impressive for patients with some blood cancers.
Sep 15, 2023
0
2
Scientists unveiled a deeper understanding of megakaryocyte differentiation and blood platelet production, a process crucial for maintaining healthy blood clotting and preventing excessive bleeding. The study featured in ...
Sep 7, 2023
0
66
Aside from transfusions, there currently is no way to boost people's platelet counts, leaving them at risk for uncontrolled bleeding. Could something as simple as a dietary change raise platelet counts in people with low ...
Aug 23, 2023
0
15
The trend in hospitals and guidelines is to be increasingly cautious with blood transfusions. Due to side effects associated with blood transfusion and the increasing scarcity and costs of blood products. For example, in ...
May 24, 2023
1
77
HealthPartners Institute researchers have published new data in JAMA Network Open that show monovalent COVID-19 booster vaccinations administered in early pregnancy (before 20 weeks' gestation) were not associated with miscarriage. ...
May 19, 2023
0
60
Babesiosis, a tick-borne disease, is endemic in 10 U.S. states, according to a March report by the Atlanta-based Centers for Disease Control and Prevention (CDC). The parasitic disease primarily occurs within the Northeast ...
Mar 22, 2023
0
21
A study published by The BMJ today sheds further light on the risk of developing a very rare blood-clotting condition known as thrombosis with thrombocytopenia syndrome (TTS) after vaccination against the COVID-19 virus.
Oct 26, 2022
0
76
A new discovery from the University of Virginia School of Medicine could let doctors ramp up production of blood-clotting platelets on demand, a timely finding following the Red Cross' declaration earlier this year of a national ...
Sep 23, 2022
0
15
The U.S. Food and Drug Administration has approved Imbruvica (ibrutinib) for pediatric patients with chronic graft versus host disease (cGVHD) after failure of one or more lines of systemic therapy.
Aug 29, 2022
0
13